Retatrutide
20 mg
A triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors for comprehensive metabolic support. It is studied for its potential to improve appetite regulation, increase energy expenditure, and support healthy blood glucose control.
Select dosage
GLP-1 / GIP / GlucagonFat LossAppetite Control
₼400.00
1
You'll be redirected to WhatsApp to complete your request
Research Benefits
Triple Receptor Activation
Targets GLP-1, GIP, and glucagon receptors simultaneously for enhanced metabolic effects.
Appetite Regulation
Supports natural appetite control through multiple signaling pathways.
Metabolic Enhancement
Research suggests improved glucose metabolism and lipid profiles.
Body Composition
Studies indicate potential for significant fat mass reduction while preserving lean tissue.
